Pneumonia
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Family of patients admitted with pneumonia and their doctor
Exclusion criteria
Exclusion criteria: 1) Patients with advanced malignant tumor. 2) Pregnant patients. 3) Patients with new coronavirus pneumonia. 4) Patients who are disqualified at the discretion of the research doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Investigating gaps in patient survival between physicians and families who received informed consent. | — |
Secondary
| Measure | Time frame |
|---|---|
| Investigate whether there is a difference in opinion regarding the number of days patients need to improve and the number of days patients need to be discharged and the physical function of the patient at the time of discharge and the food intake status at the time of discharge and the number of days required to improve the patient from their doctors and their families after receiving IC. Investigate whether there is a difference in opinion regarding the number of days required to discharge a patient and physical function of the patient at the time of discharge and the food intake status of the patient at the time of discharge and the place of discharge between a doctor and a family before receiving IC. Investigate whether there is a difference in views on patient survival and the number of days required to improve patients and the number of days required for the patient to be discharged between families before and after receiving IC. Investigate whether there is a difference in the view of the patient's physical function at discharge from the family before and after receiving IC. Investigate whether there is a difference in opinion regarding the food intake status of the patient at the time of discharge from the family before and after receiving IC. Investigate whether there is a difference in views of where the patient is discharged from the family before and after receiving IC. Analysis of the association of various clinical factors and questionnaires with information on patients' comorbidities, severity, location of treatment when hospitalized, DNAR or not. Analysis of the association of various clinical factors and questionnaires with information on family's and doctor's HADS-A, HADS-D, recurrence risk of pneumonia, pneumococcal vaccine, and comparison with various clinical factors and questionnaires. | — |
Countries
Japan
Contacts
Showa University School of Medicine Department of Medicine, Division of Respiratory Medicine and Allergology